Richard O'Brien

Integrated Guidance for Enhancing the Care of Familial Hypercholesterolaemia in Australia

Gerald F Watts, David R Sullivan, David L Hare, Karam M Kostner, Ari E Horton, Damon A Bell, Tom Brett, Ronald J Trent, Nicola K Poplawski, Andrew C Martin, Shubha Srinivasan, Robert N Justo, Clara K Chow, Jing Pang

Journal article  |  2021  |  Heart Lung and Circulation

Familial hypercholesterolaemia (FH) is a dominant and highly penetrant monogenic disorder present from birth that markedly elevate..

Gaps in the Care of Familial Hypercholesterolaemia in Australia: First Report From the National Registry

Jing Pang, David R Sullivan, David L Hare, David M Colquhoun, Timothy R Bates, Jacqueline DM Ryan, Warrick Bishop, John R Burnett, Damon A Bell, Leon A Simons, Sam Mirzaee, Karam M Kostner, Paul J Nestel, Andrew M Wilson, Richard C O'Brien, Edward D Janus, Peter M Clifton, Justin J Ardill, Dick C Chan, Frank van Bockxmeer, et al.

Journal article  |  2021  |  Heart Lung and Circulation

BACKGROUND: Familial hypercholesterolaemia (FH) is under-diagnosed and under-treated worldwide, including Australia. National regi..

The Prevalence of Elevated Lipoprotein(a) in Patients Presenting With Coronary Artery Disease

Hnin P Oo, Julian Giovannucci, Richard C O'Brien, David L Hare

Journal article  |  2020  |  Heart Lung and Circulation

BACKGROUND: Elevated lipoprotein(a) (Lp(a)) is an inherited lipid disorder and an independent risk factor for cardiovascular (CV) ..

Lipoprotein apheresis andPCSK9inhibitors for severe familial hypercholesterolaemia: Experience from Australia and New Zealand

Michael M Page, Elif Ekinci, John R Burnett, Amanda J Hooper, Nicola Reid, Warrick Bishop, Chris M Florkowski, Russell Scott, Richard C O'Brien, Gerald F Watts

Journal article  |  2020  |  Journal of Clinical Apheresis

INTRODUCTION: Severe familial hypercholesterolaemia (FH) causes premature disability and death due to atherosclerotic cardiovascul..

Statin intolerance: an updated, narrative review mainly focusing on muscle adverse effects

Jian-Jun Li, Hui-Hui Liu, Na-Qiong Wu, Khung Keong Yeo, Kathryn Tan, Junya Ako, Rungroj Krittayaphong, Ru San Tan, Philip E Aylward, Sang Hong Baek, Jamshed Dalal, Alan Yean Yip Fong, Yi-Heng Li, Richard C O'Brien, Tien Siang Eric Lim, Si Ya Natalie Koh, Daniel J Scherer, Hayato Tada, Vernon Kang, Julie Butters, et al.

Journal article  |  2020  |  Expert Opinion on Drug Metabolism & Toxicology

INTRODUCTION: Statins have been established as the standard of care for dyslipidemia and preventing cardiovascular diseases while ..

Journal clubs in Australian medical schools: prevalence, application and educator opinion

Damian James Ianno, Kelly Mirowska-Allen, Stephen Anthony Kunz, Richard O'Brien

Journal article  |  2020  |  Journal of Educational Evaluation for Health Professions

What is new in lipid-lowering therapies in diabetes?

Yee-Ming Cheung, Richard O'Brien, Elif I Ekinci

Journal article  |  2019  |  Internal Medicine Journal

Diabetes can lead to a myriad of microvascular and macrovascular complications - with the leading cause of mortality in diabetes b..

Status of PCSK9 Monoclonal Antibodies in Australia

Daniel J Scherer, Adam J Nelson, Richard O'Brien, Karam M Kostner, David L Hare, David M Colquhoun, Philip J Barter, Philip Aylward, Stephen J Nicholls, Gerald F Watts

Journal article  |  2019  |  Heart Lung and Circulation

Proprotein convertase subtilisin/kexin type 9 (PCSK9) monoclonal antibodies (mAb) have progressed from showing marked low density ..

THE PREVALENCE OF FAMILIAL HYPERCHOLESTEROLAEMIA IN PATIENTS PRESENTING WITH CLINICAL CORONARY ARTERY DISEASE

J Giovannucci, H Oo, R O'Brien, D Hare

Conference Proceedings  |  2019  |  Atherosclerosis

DISTRIBUTION OF ELEVATED LIPOPROTEIN(A) IN PATIENTS PRESENTING WITH CLINICAL CORONARY ARTERY DISEASE

H Oo, J Giovannucci, D Hare, R O'Brien

Conference Proceedings  |  2019  |  Atherosclerosis